drugset / Trial / NCT03132155
QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 2 study that will assess the efficacy of AMG 337 in subjects with advanced or metastatic clear cell sarcoma that contains the EWSR1-ATF1 gene fusion.
Timeline
- Start
- 2018-08-29
- Primary completion
- 2021-08-13
- Completion
- 2021-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMG 337 | Small molecule | — | — |